Efficacy of adjuvant vascular endothelial growth factor receptor (VEGFR) tyrosine kinase inhibitors (VEGFRi) in renal-cell carcinoma (RCC): Systematic review and meta-analysis.

Growth Factor ◽

Renal Cell ◽

Kinase Inhibitors ◽

Meta Analysis ◽

Growth Factor Receptor ◽

Vascular Endothelial ◽

Risks of Proteinuria Associated with Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitors in Cancer Patients: A Systematic Review and Meta-Analysis

PLoS ONE ◽

10.1371/journal.pone.0090135 ◽

2014 ◽

Vol 9 (3) ◽

pp. e90135 ◽

Cited By ~ 31

Author(s):

Ze-Feng Zhang ◽

Tao Wang ◽

Li-Hua Liu ◽

Hui-Qin Guo

Keyword(s):

Systematic Review ◽

Growth Factor ◽

Receptor Tyrosine Kinase ◽

Kinase Inhibitors ◽

Meta Analysis ◽

Growth Factor Receptor ◽

Vascular Endothelial ◽

Receptor Tyrosine Kinase Inhibitors

Clinical outcomes of patients with metastatic renal cell carcinoma (mRCC) treated with vascular endothelial growth factor receptor (VEGFR) tyrosine kinase inhibitors (TKI) and mammalian target of rapamycin inhibitors (mTORI) after immuno-oncology (IO) checkpoint inhibitors

Annals of Oncology ◽

10.1093/annonc/mdy283.098 ◽

2018 ◽

Vol 29 ◽

pp. viii315 ◽

Cited By ~ 1

Author(s):

J. Graham ◽

J.C. Wells ◽

R. McKay ◽

U.N. Vaishampayan ◽

A. Hansen ◽

...

Keyword(s):

Renal Cell Carcinoma ◽

Growth Factor ◽

Renal Cell ◽

Kinase Inhibitors ◽

Checkpoint Inhibitors ◽

Mammalian Target Of Rapamycin ◽

Growth Factor Receptor ◽

Vascular Endothelial ◽

Risk of gastrointestinal perforation in cancer patients treated with vascular endothelial growth factor receptor tyrosine kinase inhibitors: A systematic review and meta-analysis

Critical Reviews in Oncology/Hematology ◽

10.1016/j.critrevonc.2013.10.002 ◽

2014 ◽

Vol 89 (3) ◽

pp. 394-403 ◽

Cited By ~ 46

Author(s):

Wei-Xiang Qi ◽

Yuan-Jue Sun ◽

Li-Na Tang ◽

Zan Shen ◽

Yang Yao

Keyword(s):

Systematic Review ◽

Growth Factor ◽

Receptor Tyrosine Kinase ◽

Kinase Inhibitors ◽

Meta Analysis ◽

Growth Factor Receptor ◽

Vascular Endothelial ◽

Receptor Tyrosine Kinase Inhibitors

Expression level of vascular endothelial growth factor receptor-2 in radical nephrectomy specimens as a prognostic predictor in patients with metastatic renal cell carcinoma treated with sunitinib

Urologic Oncology Seminars and Original Investigations ◽

10.1016/j.urolonc.2011.02.012 ◽

2013 ◽

Vol 31 (4) ◽

pp. 493-498 ◽

Cited By ~ 28

Author(s):

Tomoaki Terakawa ◽

Hideaki Miyake ◽

Yuji Kusuda ◽

Masato Fujisawa

Keyword(s):

Renal Cell Carcinoma ◽

Growth Factor ◽

Cell Carcinoma ◽

Renal Cell ◽

Radical Nephrectomy ◽

Growth Factor Receptor ◽

Vascular Endothelial ◽

Prognostic Predictor ◽

Everolimus in Patients with Metastatic Renal Cell Carcinoma Who Progress after Initial Vascular Endothelial Growth Factor Receptor-Tyrosine Kinase Inhibitor (VEGFR-TKI) Therapy: UK Results from the react Trial on Behalf of the UK React Investigators

Annals of Oncology ◽

10.1016/s0923-7534(20)33390-1 ◽

2012 ◽

Vol 23 ◽

pp. ix271-ix272

Author(s):

S. Chowdhury ◽

J. Larkin

Keyword(s):

Renal Cell Carcinoma ◽

Growth Factor ◽

Receptor Tyrosine Kinase ◽

Renal Cell ◽

Kinase Inhibitor ◽

Growth Factor Receptor ◽

Vascular Endothelial ◽

The Uk ◽

Association of hand-foot syndrome (HFS), treatment dose reductions (TDRs), and outcomes in patients (pts) with metastatic renal cell carcinoma (mRCC) treated with vascular endothelial growth factor (VEGF) tyrosine kinase inhibitors (TKIs).

Journal of Clinical Oncology ◽

10.1200/jco.2014.32.15_suppl.4580 ◽

2014 ◽

Vol 32 (15_suppl) ◽

pp. 4580-4580

Author(s):

Erin B. Bailey ◽

Srinivas Kiran Tantravahi ◽

Austin Poole ◽

Chesley E. Wells ◽

Julia A. Batten ◽

...

Keyword(s):

Renal Cell Carcinoma ◽

Growth Factor ◽

Renal Cell ◽

Kinase Inhibitors ◽

Vascular Endothelial ◽

Treatment Dose ◽

Hand Foot Syndrome ◽

Dose Reductions

Vascular endothelial growth factor gene polymorphisms and renal cell carcinoma: A systematic review and meta-analysis

Oncology Letters ◽

10.3892/ol.2013.1499 ◽

2013 ◽

Vol 6 (4) ◽

pp. 1068-1078 ◽

Cited By ~ 9

Author(s):

YONG ZHANG ◽

SHENG LI ◽

HOU-QIN XIAO ◽

ZHAO-XIONG HU ◽

YAN-CHENG XU ◽

...

Keyword(s):

Systematic Review ◽

Renal Cell Carcinoma ◽

Growth Factor ◽

Gene Polymorphisms ◽

Meta Analysis ◽

Vascular Endothelial ◽

Factor Gene ◽

Growth Factor Gene ◽

Development of Response Classifier for Vascular Endothelial Growth Factor Receptor (VEGFR)-Tyrosine Kinase Inhibitor (TKI) in Metastatic Renal Cell Carcinoma

Pathology & Oncology Research ◽

10.1007/s12253-017-0323-2 ◽

2017 ◽

Vol 25 (1) ◽

pp. 51-58 ◽

Cited By ~ 3

Author(s):

Heounjeong Go ◽

Mun Jung Kang ◽

Pil-Jong Kim ◽

Jae-Lyun Lee ◽

Ji Y. Park ◽

...

Keyword(s):

Renal Cell Carcinoma ◽

Growth Factor ◽

Cell Carcinoma ◽

Renal Cell ◽

Kinase Inhibitor ◽

Growth Factor Receptor ◽

Vascular Endothelial ◽

Vegfr Tyrosine Kinase Inhibitor

Single nucleotide polymorphisms of the vascular endothelial growth factor receptor - a promising biomarker in metastatic renal cell carcinoma

BJU International ◽

10.1111/bju.13617 ◽

2016 ◽

Vol 118 (6) ◽

pp. 847-848

Author(s):

Solomon L. Woldu ◽

Vitaly Margulis

Keyword(s):

Renal Cell Carcinoma ◽

Growth Factor ◽

Single Nucleotide Polymorphisms ◽

Renal Cell ◽

Growth Factor Receptor ◽

Vascular Endothelial ◽

Nucleotide Polymorphisms ◽

Single Nucleotide ◽

Association between vascular endothelial growth factor gene polymorphisms and the risk and prognosis of renal cell carcinoma: A systematic review and meta-analysis

Oncotarget ◽

10.18632/oncotarget.17293 ◽

2017 ◽

Vol 8 (30) ◽

pp. 50034-50050 ◽

Cited By ~ 8

Author(s):

Jingyuan Tang ◽

Zhiqiang Qin ◽

Xiao Li ◽

Peng Han ◽

Feng Wang ◽

...

Keyword(s):

Systematic Review ◽

Renal Cell Carcinoma ◽

Growth Factor ◽

Gene Polymorphisms ◽

Meta Analysis ◽

Vascular Endothelial ◽

Factor Gene ◽

Growth Factor Gene ◽